Xtant Medical Announces Record Third Quarter Revenue of $25 Million

  Increases 2023 annual revenue guidance to $88 million – $91 million BELGRADE, Mont., November 09, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal conditions, today reported financial and operating results for the third quarter ended September 30,…